| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.042 | 0.5 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.5 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.5 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |